Indiana University
MAPS & DIRECTIONS Maps FIND PEOPLE Find People

Publications | PredictER

PredictER Menu
PredictER Portal
About
Events
Publications
Information Services
News Listserv | Archive
Team
Articles and Papers
Papers - 2011
Papers - 2010
Papers - 2009
Papers - 2008
Papers - 2007
Presentations
Presentations - 2007

Articles, Comments and White Papers

2011

Cornetta K, Meslin EM. Ethical and scientific issues in gene therapy and stem cell research. In Chadwick R, ten Have H, Meslin EM, Editors. The SAGE handbook of health care ethics. London: Sage Publications, 2011. p. 356-67.

Chen JY, Xu H, Shi P, Culbertson A, Meslin EM. Ethics and privacy considerations for systems biology applications in predictive and personalized medicine. In Liu LA, Wei D, Li Yixue, Lei H, editors. Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications. Hershey, PA: IGI Global, 2011. p. 1-27.

Drabiak-Syed K. Currents in contemporary bioethics: waiving informed consent to prenatal screening and diagnosis? Problems with paradoxical negotiation in surrogacy contracts. J Law Med Ethics. 2011 Fall;39(3):559-64. PubMed PMID: 21871050

Drabiak-Syed K. Legal regulation of banking newborn blood spots for research: how Bearder and Beleno resolved the question of consent. Houston Journal of Health Law & Policy. 2011 Fall;11(1):1-45.

Meslin EM, Garba I. Biobanking and public health: is a human rights approach the tie that binds? Hum Genet. 2011 Jul 15. PubMed PMID: 21761137.

Haas DM, Gallauresi B, Shields K, Zeitlin D, Clark SM, Hebert MF, Ren Z, Nallani SC, Meslin EM, Feibus KB, Koren G, Goebel WS, Easterling T, Denne SC, Flockhart DA, Renbarger JL. Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci. 2011 Jun;4(3):204-9. doi:10.1111/j.1752-8062.2011.00280.x. PubMed PMID: 21707952.

Evans JP, Meslin EM, Marteau TM, Caulfield T. Genomics. Deflating the genomic bubble. Science. 2011 Feb 18;331(6019):861-2. PubMed PMID: 21330519.

2010

Meslin EM. The value of using top-down and bottom-up approaches for building trust and transparency in biobanking. Public Health Genomics. 2010;13(4):207-14. Abstract: http://pubmed.gov/20395689

Williams JK, Erwin C, Juhl AR, Mengeling M, Bombard Y, Hayden MH, Quaid KA, Shoulson I, Taylor S, Paulsen JS, and the Investigators of the Huntington Study Group. In their own words: experiences of stigma and genetic discrimination by people at-risk for Huntington disease in the international RESPOND-HD study. American Journal of Medical Genetics Part B. [in press]

Erwin C, Williams JK, Juhl A, Mengeling M, Mills Jal Bombard Y, Hayden M, Shoulson I, Taylor S, Paulsen JS, Quaid KA, and the Investigators of the Huntington Study Group. Perception, experience and response to genetic discrimination in Huntington: The international RESPOND-HD study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2009 July;153B(5):1081-1093. Abstract: http:/pubmed.gov/20468061

Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA.  Variable judgments of decisional capacity in cognitively impaired research subjects. J Am Geriatr Soc 2008;56(10):1893-1897. [Best paper (ethics and quality of life) at Annual Meeting of American Geriatrics Society] Abstract: http://pubmed.gov/19054202

Drabiak-Syed K. Baby gender mentor: class action litigation calls attention to a deficient federal regulatory framework for DTC genetic tests, politicized state statutory construction, and a lack of informed consent. Michigan State University Journal of Medicine and Law. 2010 winter;14(1):71-92. Abstract: http://www.citeulike.org/user/cntbioet/article/8345249

Schwartz PH. 2009 Walter C. Randall Lecture in Bioethics. Autonomy and consent in biobanks. Physiologist. 2010 Feb;53(1):1,3-7. Abstract: http://pubmed.gov/20222497

2009

Kimmelman J, Weijer C, Meslin EM. Helsinki discords: FDA, ethics, and international drug trials. Lancet. 2009 Jan 3;373(9657):13-4. [PMID: 19121708 | Excerpt]

Sly PD, Eskenazi B, Pronczuk J, Srám R, Diaz-Barriga F, Machin DG, Carpenter DO, Surdu S, Meslin EM. Ethical issues in measuring biomarkers in children's environmental health. Environmental Health Perspectives. 2009 Aug;117(8):1185-90. Abstract: http://pubmed.gov/19672395

Drabiak-Syed K. State codification of federal regulatory ambiguities in biobanking and genetic research. The Journal of Legal Medicine. 2009;30:299-327. Abstract: http://pubmed.gov/19681010

Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA; REVEAL Study Group. Disclosure of APOE genotype for risk of Alzheimer's disease. New England Journal of Medicine. 2009 Jul 16;361(3):245-54. Abstract: http://pubmed.gov/19605829

Schwartz PH. Disclosure and rationality: Comparative risk information and decision-making about prevention. Theor Med Bioeth. June 2009;30:199-213. Abstract: http://pubmed.gov/19551490

Vreeman RC, Nyandiko W, Meslin EM. Pediatric assent for a study of antiretroviral therapy dosing for children in western Kenya: a case study in international research collaboration. Journal of Empirical Research on Human Research Ethics. 2009;4(1):3-16. Abstract: http://pubmed.gov/19374483

Haas DM, Jamie L. Renbarger, JL, Denne, S,. Ahmed, MS, Easterling, T, Feibus K, Meslin EM, Koren G, Zajicek A, Snodgrass, WR, Flockhart DA. Summary of proceedings of the first international conference for individualized pharmacotherapy in pregnancy, clinical and translational science (2009);2:11-14. [Published Online: 18 Feb 2009] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1752-8062.2009.00079.x/abstract

Quaid KA. Presymptomatic genetic testing in children. In Miller G, editor. Pediatric Bioethics. New York: Cambridge University Press, 2009. p. 125-40.

Quaid KA. Presymptomatic testing in Huntington disease. The Marker. Huntington Disease Society of America. 2009 May.

Oster E, Shoulson I, Quaid KA, and Dorsey ER. Genetic adverse selection: evidence from long term care insurance and Huntington disease. NBER Working Paper No. 15326, 2009 Sep. Abstract: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1469120

Schwartz PH. Risk and disease. Perspect Biol Med. 2008 Summer;51(3):320-34. Abstract: http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v051/51.3.schwartz.html

Schwartz PH. Disclosure and rationality: comparative risk information and decision-making about prevention. Theor Med Bioeth. 2009;30(3):199-213. Abstract: http://pubmed.gov/19551490

Drabiak-Syed K. Revisiting the USPTO’s examination guidelines for gene patents: congressional inaction, USPTO restraint, and judicial remedy. Journal of International Biotechnology Law. 2009 Oct 5;6(5):204-209. Abstract: http://www.reference-global.com/doi/abs/10.1515/JIBL.2009.27

Schwartz PH. The value of information and the ethics of personal genomic screening. American Journal of Bioethics. 2009 Apr 1;9(4):26-27. Abstract: http://pubmed.gov/19326308

Schwartz PH. Autonomy and consent in biobanks.  The Physiologist. 2009 Nov. Available from: http://www.the-aps.org/publications/tphys/2010html/February/randall_lecture.htm

2008

  • Haas DM, Renbarger JL, Meslin EM, Drabiak K, Flockhart D. Patient attitudes toward genotyping in an urban women's health clinic. Obstet Gynecol. 2008 Nov;112(5):1023-8. [Abstract]

  • Dure LS, Quaid K, Beasley TM. A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families. Genet Med. 2008 Nov;10(11):811-9. [Abstract]

  • Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K, and the Huntington Study Group PHAROS Investigators. Fear of health insurance loss among individuals at risk for Huntington disease. Am J Med Genet A. 2008 August 15; 146A(16): 2070–2077. [Full text]

  • Schwartz PH, Meslin EM. The ethics of information: absolute risk reduction and patient understanding of screening. J Gen Intern Med. 2008 Jun;23(6):867-70. [Abstract]

  • Meslin EM. The stem cell decade: what have we learned? J Cardiovasc Trans Res. 2008 Jun;1(2):95. [Abstract]

  • Schwartz PH. Risk and disease. Perspectives in Biology and Medicine. 2008;51(3):320-334. [Abstract]

  • Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray PN, Sugarman J, Timmons M. Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol. 2008 Mar 25;6(3):e73. [Full text]

  • Quaid KA, Sims SL, Swenson MM, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Westphal BJ. Living at risk: concealing risk and preserving hope in Huntington disease. J Genet Couns. 2008 Feb;17(1):117-28. [Abstract]

  • Quaid KA. Ethical and legal issues in molecular testing. In: Cheng L, Zhang D, editors. Essentials of molecular genetic pathology. Totowa, NJ: Humana Press; 2008. p. 731-736.

  • Quaid KA. Genetic counseling. In: Cheng L, Zhang D, editors. Essentials of molecular genetic pathology. Totowa, NJ: Humana Press; 2008. p. 405-413.

  • Meslin EM, Dickens BM. Research ethics. In: Singer PA, Viens AM, editors. The Cambridge textbook of bioethics. Cambridge: Cambridge UP; 2008. p. 187-193.

  • Meslin EM, Johnson S. Codes, declarations, and other ethical guidance for research with humans. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, Wendler D, editors. The Oxford textbook of clinical research ethics. New York: Oxford UP; 2008. p. 187-197.

  • Meslin EM, Rooney PM, Wolf JG. Health-related philanthropy: toward understanding the relationship between the body (and its parts) and traditional forms of philanthropic giving. Nonprofit and Voluntary Sector Quarterly. 2008;37(1):44S-62S. [Abstract]

  • Girod J, Drabiak K. A proposal for comprehensive biobank research laws to promote [translational] medicine in Indiana. Indiana Health Law Review 2008;5(2).

  • Girod J. Translating the promise of genetic research. Counselor [Sommer Barnard PC] 2008: 13. [Full text - PDF, 88 KB]

  • Barrett PR, Meslin EM, Schwartz PH, Girod J, Odell JD, Quaid K, Wolf J. Report from the PredictER Expert Panel Meeting, November 2, 2007. Indiana University Center for Bioethics, January 7, 2008. Available from: http://hdl.handle.net/1805/1711

2007

  • Schwartz PH. Silence about screening. Am J Bioeth. 2007 Jul;7(7):46-8. [PMID: 17654387 | Excerpt]

  • Stanley FJ, Meslin EM. Australia needs a better system for health care evaluation. Med J Aust. 2007 Mar 5;186(5):220-1. [Full text]

  • Helft PR, Champion VL, Eckles R, Johnson CS, Meslin EM. Cancer patients' attitudes toward future research uses of stored human biological material. JERHRE. 2007 Sept;2(3):15-22. [Abstract]

  • Schwartz PH. Defining dysfunction: natural selection, design, and drawing the line. Philosophy of Science. 2007;74(7): 364-85. [Abstract]

  • Schwartz PH. Decision and discovery in defining disease. In: Kincaid H, McKitrick J, editors. Establishing medical reality: essays in the metaphysics and epistemology of biomedical science. Dordrecht: Springer; 2007. p. 47-64.

  • Caulfield T, Brown R, Meslin EM. Challenging a well established consent norm? One time consent for biobank research. JIBL 2007;4(2):69-74. [Abstract]

2006

  • Tempel ER, Meslin E. Volunteers give of themselves, literally. The NonProfit Times Weekly. 2006 Oct 9. [Full text]

  • Evans BJ, Meslin EM. Encouraging translational research through harmonization of FDA and common rule informed consent requirements for research with banked specimens. J Leg Med. 2006 Jun;27(2):119-66. [PMID: 16728351 | Excerpt]

  • Meslin EM. Shifting paradigms in health services research ethics. Consent, privacy, and the challenges for IRBs. J Gen Intern Med. 2006 Mar;21(3):279-80. [Full text]

Presentations

Presentations - 2008

  • Meslin EM. Ethical issues in constructing and using biobanks. Presented at: Purdue Bioethics Lecture Series. 2008 April 16; Purdue University, West Lafayette, Indiana.

  • Haas DM. Patient attitudes toward genotyping in an urban women's health clinic. Presented at: Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. 2008 April 3; Orlando, Florida.

Presentations - 2007

  • Girod J. State law initiatives and genetic research. Presented at: The Indiana Life Sciences Collaboration Conference. 2007 Nov 16; Bloomington, Indiana.

  • Meslin EM. Biobanks as tools for personalized medicine: can good ethics and good business cohabitate? Presented at: The Indiana Life Sciences Collaboration Conference. 2007 Nov 16; Bloomington, Indiana.

  • Denne SC. Attitudes of pediatric health care professionals towards pediatric biobanks. [Panel:] Ethics and regulation of predictive health research: a new translational paradigm? Presented at: American Society for Bioethics and Humanities, Annual Meeting; 2007 Oct 21; Washington, D.C.